These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 15115003)

  • 21. In the Supreme Court of the United States Docket No. 18-102.
    Cooney D; Moriarty J; Sklar E; Hudson J
    J Leg Med; 2020; 40(3-4):467-498. PubMed ID: 33797323
    [No Abstract]   [Full Text] [Related]  

  • 22. Sword or shield? An overview and competitive analysis of the marketing of "authorized generics".
    Zain S
    Food Drug Law J; 2007; 62(4):739-77. PubMed ID: 18557229
    [No Abstract]   [Full Text] [Related]  

  • 23. Maker of growth hormone feels long arm of law.
    Nordenberg T
    FDA Consum; 1999; 33(5):33. PubMed ID: 10522170
    [No Abstract]   [Full Text] [Related]  

  • 24. Pharmaceuticals and medical devices: business practices.
    Jones TM
    Issue Brief Health Policy Track Serv; 2009 Jan; ():1-54. PubMed ID: 19297719
    [No Abstract]   [Full Text] [Related]  

  • 25. Torts--expanding the right of recovery for preconception torts.
    Breckinridge JP
    Tulane Law Rev; 1978 Jun; 52(4):893-900. PubMed ID: 11664972
    [No Abstract]   [Full Text] [Related]  

  • 26. Recent multistate enforcement initiatives: prescription drug promotional practices.
    Woodward D
    Food Drug Law J; 1995; 50(2):295-300. PubMed ID: 10342997
    [No Abstract]   [Full Text] [Related]  

  • 27. Reimagining the learned intermediary rule for the new pharmaceutical marketplace.
    Hall TS
    Seton Hall Law Rev; 2004; 35(1):193-261. PubMed ID: 15614980
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug lawsuits building. Merck, Pfizer facing charges of misrepresentation.
    Benko LB
    Mod Healthc; 2006 Apr; 36(15):16. PubMed ID: 16669517
    [No Abstract]   [Full Text] [Related]  

  • 29. Lessons from expanded government enforcement efforts against drug companies.
    Scheineson MJ; Klinger ST
    Food Drug Law J; 2005; 60(1):1-16. PubMed ID: 15940851
    [No Abstract]   [Full Text] [Related]  

  • 30. Ad venture.
    English J; Bogart S; Kattman D
    Mark Health Serv; 2006; 26(4):33-6. PubMed ID: 17330654
    [No Abstract]   [Full Text] [Related]  

  • 31. Notes and comments "High and dry?" The Public Readiness and Emergency Preparedness Act and liability protection for pharmaceutical manufacturers.
    Copper BK
    J Health Law; 2007; 40(1):65-105. PubMed ID: 17549932
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Appeal court grants Genentech's growth market to Novo Nordisk.
    Kling J
    Nat Biotechnol; 1997 May; 15(5):403. PubMed ID: 9131605
    [No Abstract]   [Full Text] [Related]  

  • 33. Drug company and pharmacy send unsolicited samples of Prozac to Florida residents.
    Dyer O
    BMJ; 2003 Oct; 327(7421):950. PubMed ID: 14576244
    [No Abstract]   [Full Text] [Related]  

  • 34. Medical call centers face more than malpractice risk.
    Healthc Demand Dis Manag; 1998 Apr; 4(4):52-3. PubMed ID: 10178982
    [No Abstract]   [Full Text] [Related]  

  • 35. Bill could create health courts. Legislation may loosen tension on malpractice suits.
    Lubell J
    Mod Healthc; 2007 May; 37(22):8-9. PubMed ID: 17612020
    [No Abstract]   [Full Text] [Related]  

  • 36. The FDA and the tort system: postmarketing surveillance, compensation, and the role of litigation.
    Struve CT
    Yale J Health Policy Law Ethics; 2005; 5(2):587-669. PubMed ID: 16052895
    [No Abstract]   [Full Text] [Related]  

  • 37. Pushing drugs: genomics and genetics, the pharmaceutical industry, and the law of negligence.
    Feldman HL
    Washburn Law J; 2003; 42(3):575-99. PubMed ID: 15115000
    [No Abstract]   [Full Text] [Related]  

  • 38. Torts: a duty to the unconceived.
    Stoll SK
    Washburn Law J; 1979; 18(3):700-8. PubMed ID: 11665192
    [No Abstract]   [Full Text] [Related]  

  • 39. Direct-to-consumer genetic tests, government oversight, and the First Amendment: what the government can (and can't) do to protect the public's health.
    Javitt GH; Stanley E; Hudson K
    Oklahoma Law Rev; 2004; 57(2):251-302. PubMed ID: 15658034
    [No Abstract]   [Full Text] [Related]  

  • 40. US pharma company fined 435 million dollars.
    McLaughlin P
    CMAJ; 2006 Oct; 175(9):1046. PubMed ID: 17060646
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.